Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02737917 · ClinicalTrials.gov registry record · NA
EmergeNcy Department Apneic Oxygenation Versus Usual Care During Rapid Sequence Intubation
A NA study of Diffuse Apneic Oxygenation, sponsored by New York City Health and Hospitals Corporation.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
- 1
- Study location
NCT02737917: Completed NA study of Diffuse Apneic Oxygenation, sponsored by New York City Health and Hospitals Corporation.
NCT02737917 is a NA study of Diffuse Apneic Oxygenation that has completed, run by New York City Health and Hospitals Corporation. The registered enrollment target is 206 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02737917, a NA study of Diffuse Apneic Oxygenation, has completed, sponsored by New York City Health and Hospitals Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the impact, if any the application of oxygen during the apnea period of rapid sequence intubation has on patients being intubated in the emergency department.
Primary Outcome
the average oxygen saturation as measured by peripheral capillary oxygen saturation (SpO2)
Conditions Studied
Interventions
- OTHER Standard of care
- OTHER Oxygen
Study Locations (1)
New York
- Lincoln Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT02737917 record still lists
NCT02737917 is an interventional study that assigns participants to a tested intervention. The registered 206 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Diffuse Apneic Oxygenation appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT02737917 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02737917 about?
NCT02737917 is a clinical study titled "EmergeNcy Department Apneic Oxygenation Versus Usual Care During Rapid Sequence Intubation". To determine the impact, if any the application of oxygen during the apnea period of rapid sequence intubation has on patients being intubated in the emergency department.
What is the current status of trial NCT02737917?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2016-05. Estimated completion is 2016-12.
What conditions does trial NCT02737917 study?
This clinical trial studies the following conditions: Diffuse Apneic Oxygenation.
What interventions are being tested in trial NCT02737917?
The interventions under investigation include: Standard of care (OTHER), Oxygen (OTHER).
Who is sponsoring clinical trial NCT02737917?
This trial is sponsored by New York City Health and Hospitals Corporation, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02737917 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02737917's enrollment target sits among peer trials
206 499th of 2000 higher than 1,502 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03373968 · 206 participants · Phase 2
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
- NCT03550391 · 206 participants · Phase 3
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- NCT04757116 · 206 participants · NA
Post-Market Study to Assess iTind Safety in Comparison to UroLift
- NCT05675865 · 206 participants · NA
Cryoablation for Monomorphic Ventricular Tachycardia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia